GlassScriptPhysician profile
Sara Blackman
NPI 1922301308
$912.15
in general payments reported to CMS, 2019-2025
17 companies · $99.99 in 2025
The $99.99 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.69 · 2022: $77.10 · 2023: $496 · 2024: $222 · 2025: $99.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $519 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $519.39 |
| Education | $298.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $221.14 | 2023 | Trodelvy |
| Genentech USA, INC. | $147.50 | 2023 | Polivy |
| Pfizer INC. | $99.99 | 2025 | |
| Sanofi-Aventis U.S. LLC | $83.99 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $54.38 | 2023 | |
| Daiichi Sankyo INC. | $53.29 | 2024 | |
| Boston Scientific Corporation | $42.07 | 2024 | Spaceoar Vue System - 10ml |
| Takeda Pharmaceuticals U.S.A., INC. | $33.34 | 2022-2023 | Ninlaro |
| Abbvie INC. | $27.60 | 2024 | |
| Tersera Therapeutics LLC | $25.03 | 2022 | |
| Incyte Corporation | $19.94 | 2022 | |
| Dendreon Pharmaceuticals LLC | $19.38 | 2023 | Provenge |
| Amgen INC. | $18.40 | 2023 | Kyprolis |
| Agios Pharmaceuticals, INC. | $17.59 | 2023 | Pyrukynd |
| Sobi, INC | $16.82 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $16.69 | 2021 | |
| Aveo Pharmaceuticals, INC. | $15.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Blackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.